$TECH Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BIO-TECHNE Corp.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in BIO-TECHNE Corp. Get notifications about new insider transactions in BIO-TECHNE Corp for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 04 2021 | TECH | BIO-TECHNE Corp | Kelderman Kim | Pres. Diagnostics & ... | Option Exercise | M | 0.00 | 1,667 | 0 | 0 | |
May 04 2021 | TECH | BIO-TECHNE Corp | Kelderman Kim | Pres. Diagnostics & ... | Payment of Exercise | F | 427.49 | 856 | 365,931 | 1,656 | 2.5 K to 1.7 K (-34.08 %) |
May 04 2021 | TECH | BIO-TECHNE Corp | Kelderman Kim | Pres. Diagnostics & ... | Buy | M | 0.00 | 1,667 | 0 | 2,512 | 845 to 2.5 K (+197.28 %) |
May 04 2021 | TECH | BIO-TECHNE Corp | Kelderman Kim | Pres. Diagnostics & ... | Option Exercise | M | 0.00 | 1,667 | 0 | 0 | |
May 04 2021 | TECH | BIO-TECHNE Corp | Kelderman Kim | Pres. Diagnostics & ... | Payment of Exercise | F | 427.49 | 856 | 365,931 | 1,656 | 2.5 K to 1.7 K (-34.08 %) |
May 04 2021 | TECH | BIO-TECHNE Corp | Kelderman Kim | Pres. Diagnostics & ... | Buy | M | 0.00 | 1,667 | 0 | 2,512 | 845 to 2.5 K (+197.28 %) |
Mar 03 2021 | TECH | BIO-TECHNE Corp | Furlow Brenda S. | SVP - General Couns ... | Option Exercise | A | 372.44 | 10,997 | 4,095,723 | 10,997 | |
Feb 18 2021 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Option Exercise | M | 94.35 | 30,000 | 2,830,500 | 36,849 | |
Feb 18 2021 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Payment of Exercise | F | 411.00 | 17,428 | 7,162,908 | 158,841 | 176.3 K to 158.8 K (-9.89 %) |
Feb 18 2021 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Buy | M | 94.35 | 30,000 | 2,830,500 | 176,269 | 146.3 K to 176.3 K (+20.51 %) |
Feb 17 2021 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Option Exercise | M | 106.59 | 10,000 | 1,065,900 | 39,942 | |
Feb 17 2021 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Option Exercise | M | 106.59 | 10,000 | 1,065,900 | 39,942 | |
Feb 17 2021 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Sell | S | 401.52 | 600 | 240,911 | 9,137 | 9.7 K to 9.1 K (-6.16 %) |
Feb 17 2021 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Sell | S | 401.52 | 600 | 240,911 | 9,137 | 9.7 K to 9.1 K (-6.16 %) |
Feb 17 2021 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Sell | S | 400.32 | 9,400 | 3,762,998 | 9,737 | 19.1 K to 9.7 K (-49.12 %) |
Feb 17 2021 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Sell | S | 400.32 | 9,400 | 3,762,998 | 9,737 | 19.1 K to 9.7 K (-49.12 %) |
Feb 17 2021 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Buy | M | 106.59 | 10,000 | 1,065,900 | 19,137 | 9.1 K to 19.1 K (+109.45 %) |
Feb 17 2021 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Buy | M | 106.59 | 10,000 | 1,065,900 | 19,137 | 9.1 K to 19.1 K (+109.45 %) |
Feb 17 2021 | TECH | BIO-TECHNE Corp | Furlow Brenda S. | SVP - General Couns ... | Option Exercise | M | 106.59 | 10,000 | 1,065,900 | 3,538 | |
Feb 17 2021 | TECH | BIO-TECHNE Corp | Furlow Brenda S. | SVP - General Couns ... | Sell | S | 399.12 | 3,326 | 1,327,461 | 6,124 | 9.5 K to 6.1 K (-35.20 %) |
Feb 17 2021 | TECH | BIO-TECHNE Corp | Furlow Brenda S. | SVP - General Couns ... | Sell | S | 398.40 | 6,674 | 2,658,891 | 9,450 | 16.1 K to 9.5 K (-41.39 %) |
Feb 17 2021 | TECH | BIO-TECHNE Corp | Furlow Brenda S. | SVP - General Couns ... | Option Exercise | M | 106.59 | 10,000 | 1,065,900 | 3,538 | |
Feb 17 2021 | TECH | BIO-TECHNE Corp | Furlow Brenda S. | SVP - General Couns ... | Buy | M | 106.59 | 10,000 | 1,065,900 | 16,124 | 6.1 K to 16.1 K (+163.29 %) |
Feb 17 2021 | TECH | BIO-TECHNE Corp | Furlow Brenda S. | SVP - General Couns ... | Sell | S | 399.12 | 3,326 | 1,327,461 | 6,124 | 9.5 K to 6.1 K (-35.20 %) |
Feb 17 2021 | TECH | BIO-TECHNE Corp | Furlow Brenda S. | SVP - General Couns ... | Sell | S | 398.40 | 6,674 | 2,658,891 | 9,450 | 16.1 K to 9.5 K (-41.39 %) |
Feb 17 2021 | TECH | BIO-TECHNE Corp | Furlow Brenda S. | SVP - General Couns ... | Buy | M | 106.59 | 10,000 | 1,065,900 | 16,124 | 6.1 K to 16.1 K (+163.29 %) |
Feb 10 2021 | TECH | BIO-TECHNE Corp | Nusse Roeland | Director | Option Exercise | M | 66.90 | 5,000 | 334,500 | 0 | |
Feb 10 2021 | TECH | BIO-TECHNE Corp | Nusse Roeland | Director | Option Exercise | M | 70.35 | 1,000 | 70,350 | 4,000 | |
Feb 10 2021 | TECH | BIO-TECHNE Corp | Nusse Roeland | Director | Sell | S | 385.08 | 6,000 | 2,310,481 | 6,765 | 12.8 K to 6.8 K (-47.00 %) |
Feb 10 2021 | TECH | BIO-TECHNE Corp | Nusse Roeland | Director | Buy | M | 66.90 | 5,000 | 334,500 | 12,765 | 7.8 K to 12.8 K (+64.39 %) |
Feb 10 2021 | TECH | BIO-TECHNE Corp | Nusse Roeland | Director | Buy | M | 70.35 | 1,000 | 70,350 | 7,765 | 6.8 K to 7.8 K (+14.78 %) |
Feb 09 2021 | TECH | BIO-TECHNE Corp | Kelderman Kim | Pres. Diagnostics & ... | Sell | S | 388.45 | 823 | 319,694 | 845 | 1.7 K to 845 (-49.34 %) |
Feb 09 2021 | TECH | BIO-TECHNE Corp | Eansor Norman David | President-Protein S ... | Option Exercise | M | 106.59 | 18,819 | 2,005,917 | 0 | |
Feb 09 2021 | TECH | BIO-TECHNE Corp | Eansor Norman David | President-Protein S ... | Option Exercise | M | 106.59 | 14,114 | 1,504,411 | 0 | |
Feb 09 2021 | TECH | BIO-TECHNE Corp | Eansor Norman David | President-Protein S ... | Sell | S | 385.59 | 1,100 | 424,151 | 1,318 | 2.4 K to 1.3 K (-45.49 %) |
Feb 09 2021 | TECH | BIO-TECHNE Corp | Eansor Norman David | President-Protein S ... | Sell | S | 384.15 | 1,900 | 729,888 | 2,418 | 4.3 K to 2.4 K (-44.00 %) |
Feb 09 2021 | TECH | BIO-TECHNE Corp | Eansor Norman David | President-Protein S ... | Sell | S | 382.60 | 3,700 | 1,415,636 | 4,318 | 8 K to 4.3 K (-46.15 %) |
Feb 09 2021 | TECH | BIO-TECHNE Corp | Eansor Norman David | President-Protein S ... | Sell | S | 381.52 | 2,900 | 1,106,395 | 8,018 | 10.9 K to 8 K (-26.56 %) |
Feb 09 2021 | TECH | BIO-TECHNE Corp | Eansor Norman David | President-Protein S ... | Sell | S | 380.50 | 12,833 | 4,882,918 | 10,918 | 23.8 K to 10.9 K (-54.03 %) |
Feb 09 2021 | TECH | BIO-TECHNE Corp | Eansor Norman David | President-Protein S ... | Sell | S | 379.63 | 4,500 | 1,708,312 | 23,751 | 28.3 K to 23.8 K (-15.93 %) |
Feb 09 2021 | TECH | BIO-TECHNE Corp | Eansor Norman David | President-Protein S ... | Sell | S | 378.29 | 6,000 | 2,269,723 | 28,251 | 34.3 K to 28.3 K (-17.52 %) |
Feb 09 2021 | TECH | BIO-TECHNE Corp | Eansor Norman David | President-Protein S ... | Buy | M | 106.59 | 18,819 | 2,005,917 | 34,251 | 15.4 K to 34.3 K (+121.95 %) |
Feb 09 2021 | TECH | BIO-TECHNE Corp | Eansor Norman David | President-Protein S ... | Buy | M | 106.59 | 14,114 | 1,504,411 | 15,432 | 1.3 K to 15.4 K (+1,070.86 %) |
Jan 20 2021 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Sell | S | 344.00 | 20,000 | 6,880,000 | 146,269 | 166.3 K to 146.3 K (-12.03 %) |
Jan 20 2021 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Sell | S | 344.00 | 20,000 | 6,880,000 | 146,269 | 166.3 K to 146.3 K (-12.03 %) |
Jan 13 2021 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Option Exercise | M | 106.59 | 10,000 | 1,065,900 | 49,942 | |
Jan 13 2021 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Sell | S | 334.98 | 2,009 | 672,983 | 9,137 | 11.1 K to 9.1 K (-18.02 %) |
Jan 13 2021 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Sell | S | 334.39 | 3,990 | 1,334,219 | 11,146 | 15.1 K to 11.1 K (-26.36 %) |
Jan 13 2021 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Sell | S | 333.23 | 2,501 | 833,415 | 15,136 | 17.6 K to 15.1 K (-14.18 %) |
Jan 13 2021 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Sell | S | 331.61 | 700 | 232,127 | 17,637 | 18.3 K to 17.6 K (-3.82 %) |
Jan 13 2021 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Sell | S | 330.27 | 400 | 132,106 | 18,337 | 18.7 K to 18.3 K (-2.13 %) |
Jan 13 2021 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Sell | S | 328.68 | 400 | 131,472 | 18,737 | 19.1 K to 18.7 K (-2.09 %) |
Jan 13 2021 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Buy | M | 106.59 | 10,000 | 1,065,900 | 19,137 | 9.1 K to 19.1 K (+109.45 %) |
Dec 09 2020 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Sell | S | 308.00 | 5,000 | 1,540,000 | 166,269 | 171.3 K to 166.3 K (-2.92 %) |
Nov 19 2020 | TECH | BIO-TECHNE Corp | Seth Alpna | Option Exercise | M | 125.05 | 3,125 | 390,781 | 0 | ||
Nov 19 2020 | TECH | BIO-TECHNE Corp | Seth Alpna | Option Exercise | M | 179.84 | 1,898 | 341,336 | 0 | ||
Nov 19 2020 | TECH | BIO-TECHNE Corp | Seth Alpna | Sell | S | 306.95 | 3,665 | 1,124,972 | 2,139 | 5.8 K to 2.1 K (-63.15 %) | |
Nov 19 2020 | TECH | BIO-TECHNE Corp | Seth Alpna | Sell | S | 305.74 | 1,358 | 415,195 | 5,804 | 7.2 K to 5.8 K (-18.96 %) | |
Nov 19 2020 | TECH | BIO-TECHNE Corp | Seth Alpna | Buy | M | 125.05 | 3,125 | 390,781 | 7,162 | 4 K to 7.2 K (+77.41 %) | |
Nov 19 2020 | TECH | BIO-TECHNE Corp | Seth Alpna | Buy | M | 179.84 | 1,898 | 341,336 | 4,037 | 2.1 K to 4 K (+88.73 %) | |
Nov 12 2020 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Option Exercise | M | 106.59 | 9,137 | 973,913 | 58,196 | |
Nov 12 2020 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Option Exercise | M | 106.59 | 3,600 | 383,724 | 67,333 | |
Nov 12 2020 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Sell | S | 307.78 | 1,100 | 338,555 | 9,137 | 10.2 K to 9.1 K (-10.75 %) |
Nov 12 2020 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Sell | S | 306.93 | 6,291 | 1,930,874 | 10,237 | 16.5 K to 10.2 K (-38.06 %) |
Nov 12 2020 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Buy | M | 106.59 | 7,391 | 787,807 | 16,528 | 9.1 K to 16.5 K (+80.89 %) |
Nov 12 2020 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Sell | S | 312.58 | 300 | 93,775 | 9,137 | 9.4 K to 9.1 K (-3.18 %) |
Nov 12 2020 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Sell | S | 311.60 | 1,002 | 312,221 | 9,437 | 10.4 K to 9.4 K (-9.60 %) |
Nov 12 2020 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Sell | S | 310.55 | 1,098 | 340,987 | 10,439 | 11.5 K to 10.4 K (-9.52 %) |
Nov 12 2020 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Sell | S | 307.74 | 100 | 30,774 | 11,537 | 11.6 K to 11.5 K (-0.86 %) |
Nov 12 2020 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Sell | S | 306.81 | 1,100 | 337,494 | 11,637 | 12.7 K to 11.6 K (-8.64 %) |
Nov 12 2020 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Buy | M | 106.59 | 3,600 | 383,724 | 12,737 | 9.1 K to 12.7 K (+39.40 %) |
Nov 10 2020 | TECH | BIO-TECHNE Corp | HIGGINS JOHN L | Option Exercise | M | 70.35 | 5,000 | 351,750 | 0 | ||
Nov 10 2020 | TECH | BIO-TECHNE Corp | HIGGINS JOHN L | Sell | S | 301.07 | 3,100 | 933,301 | 4,412 | 7.5 K to 4.4 K (-41.27 %) | |
Nov 10 2020 | TECH | BIO-TECHNE Corp | HIGGINS JOHN L | Sell | S | 299.84 | 450 | 134,928 | 7,512 | 8 K to 7.5 K (-5.65 %) | |
Nov 10 2020 | TECH | BIO-TECHNE Corp | HIGGINS JOHN L | Sell | S | 298.98 | 1,450 | 433,516 | 7,962 | 9.4 K to 8 K (-15.41 %) | |
Nov 10 2020 | TECH | BIO-TECHNE Corp | HIGGINS JOHN L | Buy | M | 70.35 | 5,000 | 351,750 | 9,412 | 4.4 K to 9.4 K (+113.33 %) | |
Nov 10 2020 | TECH | BIO-TECHNE Corp | HIGGINS JOHN L | Option Exercise | M | 70.35 | 5,000 | 351,750 | 0 | ||
Nov 10 2020 | TECH | BIO-TECHNE Corp | HIGGINS JOHN L | Sell | S | 301.07 | 3,100 | 933,301 | 4,412 | 7.5 K to 4.4 K (-41.27 %) | |
Nov 10 2020 | TECH | BIO-TECHNE Corp | HIGGINS JOHN L | Sell | S | 299.84 | 450 | 134,928 | 7,512 | 8 K to 7.5 K (-5.65 %) | |
Nov 10 2020 | TECH | BIO-TECHNE Corp | HIGGINS JOHN L | Sell | S | 298.98 | 1,450 | 433,516 | 7,962 | 9.4 K to 8 K (-15.41 %) | |
Nov 10 2020 | TECH | BIO-TECHNE Corp | HIGGINS JOHN L | Buy | M | 70.35 | 5,000 | 351,750 | 9,412 | 4.4 K to 9.4 K (+113.33 %) | |
Nov 06 2020 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Option Exercise | M | 108.49 | 8,809 | 955,688 | 0 | |
Nov 06 2020 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Option Exercise | M | 108.49 | 7,100 | 770,279 | 7,100 | |
Nov 06 2020 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Sell | S | 293.66 | 100 | 29,366 | 9,137 | 9.2 K to 9.1 K (-1.08 %) |
Nov 06 2020 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Sell | S | 291.06 | 750 | 218,297 | 9,237 | 10 K to 9.2 K (-7.51 %) |
Nov 06 2020 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Sell | S | 289.39 | 359 | 103,890 | 9,987 | 10.3 K to 10 K (-3.47 %) |
Nov 06 2020 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Sell | S | 287.98 | 3,249 | 935,648 | 10,346 | 13.6 K to 10.3 K (-23.90 %) |
Nov 06 2020 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Sell | S | 287.15 | 121 | 34,745 | 13,595 | 13.7 K to 13.6 K (-0.88 %) |
Nov 06 2020 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Sell | S | 285.12 | 1,630 | 464,740 | 13,716 | 15.3 K to 13.7 K (-10.62 %) |
Nov 06 2020 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Sell | S | 283.64 | 325 | 92,183 | 15,346 | 15.7 K to 15.3 K (-2.07 %) |
Nov 06 2020 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Sell | S | 282.52 | 1,674 | 472,939 | 15,671 | 17.3 K to 15.7 K (-9.65 %) |
Nov 06 2020 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Sell | S | 281.27 | 203 | 57,099 | 17,345 | 17.5 K to 17.3 K (-1.16 %) |
Nov 06 2020 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Sell | S | 280.28 | 398 | 111,550 | 17,548 | 17.9 K to 17.5 K (-2.22 %) |
Nov 06 2020 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Buy | M | 108.49 | 8,809 | 955,688 | 17,946 | 9.1 K to 17.9 K (+96.41 %) |
Nov 06 2020 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Sell | S | 275.79 | 1,200 | 330,952 | 9,137 | 10.3 K to 9.1 K (-11.61 %) |
Nov 06 2020 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Sell | S | 274.53 | 1,600 | 439,254 | 10,337 | 11.9 K to 10.3 K (-13.40 %) |
Nov 06 2020 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Sell | S | 273.65 | 2,745 | 751,157 | 11,937 | 14.7 K to 11.9 K (-18.70 %) |
Nov 06 2020 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Sell | S | 272.71 | 1,555 | 424,064 | 14,682 | 16.2 K to 14.7 K (-9.58 %) |
Nov 06 2020 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Buy | M | 108.49 | 7,100 | 770,279 | 16,237 | 9.1 K to 16.2 K (+77.71 %) |
Nov 06 2020 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Option Exercise | M | 108.49 | 8,809 | 955,688 | 0 | |
Nov 06 2020 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Option Exercise | M | 108.49 | 7,100 | 770,279 | 7,100 | |
Nov 06 2020 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Sell | S | 293.66 | 100 | 29,366 | 9,137 | 9.2 K to 9.1 K (-1.08 %) |
Nov 06 2020 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Sell | S | 291.06 | 750 | 218,297 | 9,237 | 10 K to 9.2 K (-7.51 %) |
Nov 06 2020 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Sell | S | 289.39 | 359 | 103,890 | 9,987 | 10.3 K to 10 K (-3.47 %) |
Nov 06 2020 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Sell | S | 287.98 | 3,249 | 935,648 | 10,346 | 13.6 K to 10.3 K (-23.90 %) |
Nov 06 2020 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Sell | S | 287.15 | 121 | 34,745 | 13,595 | 13.7 K to 13.6 K (-0.88 %) |
Nov 06 2020 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Sell | S | 285.12 | 1,630 | 464,740 | 13,716 | 15.3 K to 13.7 K (-10.62 %) |
Nov 06 2020 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Sell | S | 283.64 | 325 | 92,183 | 15,346 | 15.7 K to 15.3 K (-2.07 %) |
Nov 06 2020 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Sell | S | 282.52 | 1,674 | 472,939 | 15,671 | 17.3 K to 15.7 K (-9.65 %) |
Nov 06 2020 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Sell | S | 281.27 | 203 | 57,099 | 17,345 | 17.5 K to 17.3 K (-1.16 %) |
Nov 06 2020 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Sell | S | 280.28 | 398 | 111,550 | 17,548 | 17.9 K to 17.5 K (-2.22 %) |
Nov 06 2020 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Buy | M | 108.49 | 8,809 | 955,688 | 17,946 | 9.1 K to 17.9 K (+96.41 %) |
Nov 06 2020 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Sell | S | 275.79 | 1,200 | 330,952 | 9,137 | 10.3 K to 9.1 K (-11.61 %) |
Nov 06 2020 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Sell | S | 274.53 | 1,600 | 439,254 | 10,337 | 11.9 K to 10.3 K (-13.40 %) |
Nov 06 2020 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Sell | S | 273.65 | 2,745 | 751,157 | 11,937 | 14.7 K to 11.9 K (-18.70 %) |
Nov 06 2020 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Sell | S | 272.71 | 1,555 | 424,064 | 14,682 | 16.2 K to 14.7 K (-9.58 %) |
Nov 06 2020 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Buy | M | 108.49 | 7,100 | 770,279 | 16,237 | 9.1 K to 16.2 K (+77.71 %) |
Nov 02 2020 | TECH | BIO-TECHNE Corp | BAUMGARTNER ROBERT V | Option Exercise | A | 255.69 | 1,507 | 385,325 | 1,507 | ||
Nov 02 2020 | TECH | BIO-TECHNE Corp | BAUMGARTNER ROBERT V | Grant | A | 0.00 | 391 | 0 | 9,612 | 9.2 K to 9.6 K (+4.24 %) | |
Nov 02 2020 | TECH | BIO-TECHNE Corp | STEER RANDOLPH C | Option Exercise | A | 255.69 | 1,507 | 385,325 | 1,507 | ||
Nov 02 2020 | TECH | BIO-TECHNE Corp | STEER RANDOLPH C | Grant | A | 0.00 | 391 | 0 | 5,112 | 4.7 K to 5.1 K (+8.28 %) | |
Nov 02 2020 | TECH | BIO-TECHNE Corp | VESSEY RUPERT | Option Exercise | A | 255.69 | 1,507 | 385,325 | 1,507 | ||
Nov 02 2020 | TECH | BIO-TECHNE Corp | VESSEY RUPERT | Grant | A | 0.00 | 391 | 0 | 1,033 | 642 to 1 K (+60.90 %) | |
Nov 02 2020 | TECH | BIO-TECHNE Corp | Nusse Roeland | Option Exercise | A | 255.69 | 1,507 | 385,325 | 1,507 | ||
Nov 02 2020 | TECH | BIO-TECHNE Corp | Nusse Roeland | Grant | A | 0.00 | 391 | 0 | 12,765 | 12.4 K to 12.8 K (+3.16 %) | |
Nov 02 2020 | TECH | BIO-TECHNE Corp | KEEGAN JOSEPH D | Option Exercise | A | 255.69 | 1,507 | 385,325 | 1,507 | ||
Nov 02 2020 | TECH | BIO-TECHNE Corp | KEEGAN JOSEPH D | Grant | A | 0.00 | 391 | 0 | 2,139 | 1.7 K to 2.1 K (+22.37 %) | |
Nov 02 2020 | TECH | BIO-TECHNE Corp | HIGGINS JOHN L | Option Exercise | A | 255.69 | 1,507 | 385,325 | 1,507 | ||
Nov 02 2020 | TECH | BIO-TECHNE Corp | HIGGINS JOHN L | Grant | A | 0.00 | 391 | 0 | 4,412 | 4 K to 4.4 K (+9.72 %) | |
Nov 02 2020 | TECH | BIO-TECHNE Corp | Bushman Julie L | Option Exercise | A | 255.69 | 1,507 | 385,325 | 1,507 | ||
Nov 02 2020 | TECH | BIO-TECHNE Corp | Bushman Julie L | Grant | A | 0.00 | 391 | 0 | 480 | 89 to 480 (+439.33 %) | |
Nov 02 2020 | TECH | BIO-TECHNE Corp | Seth Alpna | Option Exercise | A | 255.69 | 1,507 | 385,325 | 1,507 | ||
Nov 02 2020 | TECH | BIO-TECHNE Corp | Seth Alpna | Grant | A | 0.00 | 391 | 0 | 2,139 | 1.7 K to 2.1 K (+22.37 %) | |
Aug 11 2020 | TECH | BIO-TECHNE Corp | Furlow Brenda S. | SVP - General Couns ... | Option Exercise | M | 0.00 | 1,724 | 0 | 0 | |
Aug 11 2020 | TECH | BIO-TECHNE Corp | Furlow Brenda S. | SVP - General Couns ... | Payment of Exercise | F | 265.76 | 849 | 225,630 | 5,186 | 6 K to 5.2 K (-14.07 %) |
Aug 11 2020 | TECH | BIO-TECHNE Corp | Furlow Brenda S. | SVP - General Couns ... | Buy | M | 0.00 | 1,724 | 0 | 6,035 | 4.3 K to 6 K (+39.99 %) |
Aug 11 2020 | TECH | BIO-TECHNE Corp | Eansor Norman David | President-Protein S ... | Option Exercise | M | 0.00 | 2,174 | 0 | 0 | |
Aug 11 2020 | TECH | BIO-TECHNE Corp | Eansor Norman David | President-Protein S ... | Payment of Exercise | F | 265.76 | 856 | 227,491 | 1,318 | 2.2 K to 1.3 K (-39.37 %) |
Aug 11 2020 | TECH | BIO-TECHNE Corp | Eansor Norman David | President-Protein S ... | Buy | M | 0.00 | 2,174 | 0 | 2,174 | 0 to 2.2 K |
Aug 11 2020 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Option Exercise | M | 0.00 | 4,438 | 0 | 0 | |
Aug 11 2020 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Payment of Exercise | F | 265.76 | 2,184 | 580,420 | 9,137 | 11.3 K to 9.1 K (-19.29 %) |
Aug 11 2020 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Buy | M | 0.00 | 4,438 | 0 | 11,321 | 6.9 K to 11.3 K (+64.48 %) |
Aug 11 2020 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Option Exercise | M | 0.00 | 21,291 | 0 | 0 | |
Aug 11 2020 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Payment of Exercise | F | 265.76 | 12,287 | 3,265,393 | 161,487 | 173.8 K to 161.5 K (-7.07 %) |
Aug 11 2020 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Buy | M | 0.00 | 21,291 | 0 | 173,774 | 152.5 K to 173.8 K (+13.96 %) |
Aug 07 2020 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Option Exercise | A | 267.87 | 16,650 | 4,460,036 | 16,650 | |
Aug 07 2020 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Option Exercise | A | 267.87 | 16,650 | 4,460,036 | 16,650 | |
Aug 07 2020 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Option Exercise | A | 267.87 | 38,295 | 10,258,082 | 38,295 | |
Aug 07 2020 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Option Exercise | A | 267.87 | 57,442 | 15,386,989 | 57,442 | |
Aug 07 2020 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Option Exercise | A | 0.00 | 12,879 | 0 | 12,879 |